- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$3.82 BnMarket Estimate, 2026
$4.10 BnMarket Forecast, 2034
$7.20 BnCAGR, 2026–2034
7.30%North America Coronary Stents Market Size, Growth, Trends & Forecast (2026–2034)
The North America coronary stents market size was valued at USD 3.82 billion in 2025, reached USD 4.10 billion in 2026, and is anticipated to be worth USD 7.20 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.30% during the forecast period from 2026 to 2034. Driven by a rapidly growing geriatric population, escalating prevalence of cardiovascular diseases linked to lifestyle choices, and continuous product innovations in minimally invasive devices, the market reflects steady regional expansion.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 3.82 Billion
- 2026 Current Valuation: USD 4.10 Billion
- 2034 Forecast Valuation: USD 7.20 Billion
- Compound Annual Growth Rate (CAGR): 7.30% (2026–2034)
- Dominant Regional Position: United States (Leads the North American market through advanced healthcare infrastructure and high minimally invasive procedure volumes)
- Fastest-Growing Country: Canada (Projected to witness the highest CAGR driven by rising medical device demand and minimally invasive procedure adoption)
Core Market Drivers & Growth Triggers
- Demographic & Lifestyle Shifts: An aging population pool combined with unhealthy lifestyle patterns such as smoking and alcohol intake increasing cardiovascular risks.
- Favorable Frameworks & Product Launches: Supportive government and private reimbursement policies alongside aggressive commercialization of creative new stent variants by key market players.
Primary Market Restraints & Challenges
- High Costs & Access Barriers: Expensive treatment procedures rendering options less affordable for ordinary patients, alongside a shortage of skilled cardiology professionals.
- Regulatory & Technical Hurdles: Strict product approval guidelines, risk of device failure, and availability of alternative treatment methods limiting broader market penetration.
North America Coronary Stents Market Segmentation Breakdown
| Segment Category | Largest Segment / Leader | Fastest-Growing Segment |
|---|---|---|
| By Type | Drug-Eluting Stents (Maintains dominant clinical preference for preventing restenosis) | Bioabsorbable Stents (Gaining traction through advanced temporary vessel scaffolding tech) |
| By Material | Metallic Stents (Cobalt-chromium and Platinum-chromium widely utilized for structural durability) | Nickel-Titanium & Advanced Alloys (Propelled by flexible self-expanding mechanism benefits) |
| By End-User | Hospitals & Cardiac Centers (Primary clinical hubs handling high-volume cardiovascular interventions) | Ambulatory Surgical Centers (Expanding due to outpatient procedure shifts and cost efficiencies) |
| By Country | The United States (Commands the largest regional revenue share supported by advanced surgical setups) | Canada (Expected to record the highest CAGR driven by growing medical device demand and lower pain procedures) |
Major Industry Players Profiled
Key corporations shaping the North American coronary stents market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Stentys SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts, and Translumina GmbH.
North America Coronary Stents Market Size
The North America coronary stents market size was valued at USD 3.82 billion in 2025, estimated at USD 4.10 billion in 2026, and is projected to reach USD 7.20 billion by 2034, growing at a CAGR of 7.30% from 2026 to 2034.
Increasing usage of these coronary stents in the healthcare sector is one factor boosting the market over the period. The growing older people population and lack of awareness about the heart-related stents are propelling the growth. In addition, unhealthy lifestyle changes like the intake of alcohol and smoking, the launch of new creative products that assist the companies in gaining profits surge the market demand.
Favorable reimbursement policies from government and other private organizations and having sound knowledge about the related heart stent increase and drive market growth. Growing demand for catheters, stents, and balloons accelerates the growth.
The cost associated with the treatment is so expensive, unaffordable for ordinary people, hampering the market growth. Lack of awareness among the patients for early diagnosis of the treatment, the shortage of expert professionals in the cardiology field for the treatment, strict regulations for the approval of products, and their launch are also impeding the market. In addition, alternative methods during the treatment of coronary stent disorders are limiting growth. Failure of the device products and also the cancellation of the outcomes of the coronary stent market may also restrict the growth.
REGIONAL ANALYSIS
Regionally, the North American region has occupied a significant share of the market in the global 2024. The North American region accounts for the largest share and dominates the coronary stents market during the period. The growth of this region is attributed to factors such as advanced technologies by the key players coming up with the new devices into the market. Growing focus on inventing new device launches is propelling the market growth of this region.
The United States coronary stents market is leading the coronary stents market with the largest share of this region. The growth is due to minimally invasive surgeries and increasing the geriatric population, accelerating the coronary stents market growth during the review period. Also, a considerable number of key players focusing on producing stents and growing awareness related to the risk factors for coronary heart diseases is enhancing the market.
Canadian coronary stents market is expected to witness the highest growth with the highest CAGR of the coronary stents market over the analysis period. It owes to the growing demand for these procedures due to advantages like less pain, reduces scarring, and some factors that fuel the market. In addition, Canada is estimated to have a quick growth rate due to factors such as growing stipulations for medical devices with expansion in the coronary stent devices market.
KEY MARKET PLAYERS
A few of the promising companies operating in the North American coronary stents market include
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Biosensors International Group, Ltd.
- BIOTRONIK SE & Co. KG
- B. Braun Melsungen AG
- TERUMO CORPORATION
- STENTYS SA
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- Vascular Concepts
- Translumina GmbH
MARKET SEGMENTATION
This research report on North American has been segmented & sub-segmented into the following categories.
By Type
- Bare metal stents
- Drug-eluting stents
- Bioabsorbable stents
By Mode of Delivery
- Balloon expandable stents
- Self-expanding stents
By Material
- Metallic stents
- Cobalt chromium
- Platinum chromium
- Nickel-titanium
- Stainless steel
- Other Stents
By End-User
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
By Country
- The United States
- Canada
- Rest of North America